DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler (pMDI) which shows comparable performance to Ventolin® HFA but with a significant reduction in greenhouse gas emissions.
First-in-Class Drug Approved for Heavily Pretreated Myeloma
The FDA granted accelerated approval to talquetamab (Talvey) for treating adults with relapsed or refractory multiple myeloma who have received at least four prior lines
August 11, 2023